Skip to main content
. Author manuscript; available in PMC: 2016 May 31.
Published in final edited form as: JAMA. 2016 Apr 5;315(13):1400–1402. doi: 10.1001/jama.2016.0126

Figure. Mean Expenditure per Patient for Antihyperglycemic Medications, 2002–2013.

Figure

Medications were classified as follows: insulin (human and analog); newer oral therapies (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, and combinations); older oral therapies (metformin, sulfonylureas, α-galactosidase inhibitors, and nonsulfonylurea secretagogues); noninsulin-based injectable therapies (glucagon-like peptide-1 receptor agonists and amylin analogs).